MARKET

AORT

AORT

Artivion, Inc.
NYSE
23.65
-0.11
-0.46%
After Hours: 23.65 -0.01 -0.04% 16:07 05/23 EDT
OPEN
23.69
PREV CLOSE
23.76
HIGH
23.94
LOW
23.41
VOLUME
189.26K
TURNOVER
0
52 WEEK HIGH
25.51
52 WEEK LOW
12.16
MARKET CAP
987.02M
P/E (TTM)
-90.4744
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at AORT last week (0513-0517)?
Weekly Report · 3d ago
Weekly Report: what happened at AORT last week (0506-0510)?
Weekly Report · 05/13 09:22
Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher
Artivion's (NYSE:AORT) return on capital employed is 6.0%. This is a low rate of return for the medical equipment industry. The company has been growing its return on Capital employed over the last five years. Artivion has a good rate of reinvesting its money into its business. The stock has declined 21% in the last year. It's the type of company that can compound returns to a higher level. Simply Wall St likes to look for companies with growing returns on capital.
Simply Wall St · 05/08 11:43
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Beyond, Inc. Shares dipped 20.8% to $17.34 on Tuesday. The company posted weaker-than-expected quarterly results. Beyond posted adjusted loss of $1.22 per share, versus estimates for a loss of 87 cents per share. Golden Sun Health Technology Group Limited shares gained 94.7% in today's mid-day session.
Benzinga · 05/07 18:35
Artivion, Inc. Quarterly Report: Financial Statements and Analysis
Press release · 05/07 16:58
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
Shares of Tempur Sealy International, Inc. Rose sharply following upbeat quarterly earnings. The Dow Jones gained over 80 points on Tuesday. Great Lakes Dredge & Dock Corporation shares jumped 31.5% to $9.26. Summit Therapeutics Inc. Shares rose 7% after the company reported better-than-expected quarterly results.
Benzinga · 05/07 14:53
Artivion Is Maintained at Buy by Stifel
Dow Jones · 05/07 13:00
Artivion Price Target Raised to $25.00/Share From $22.00 by Stifel
Dow Jones · 05/07 13:00
More
About AORT
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.

Webull offers Artivion Inc stock information, including NYSE: AORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AORT stock methods without spending real money on the virtual paper trading platform.